Member Info for BuenaVista

Try running these two queries in Google to see the differences in effectiveness between blood cancers and solid tumours (I can't find a way to provide URLs from my phone).

can gene therapy be used to cure hematological cancers

can gene therapy be used to cure solid tumour cancers

You'll twig how the drug development process works one day, I'm sure.

LB, how do you consider solid tumours could be knocked out at core using gene therapy or CAR T-cell tech?

The Covid spike was unrelated to Avacta's core oncology business and was exaggerated because it was fueled by furlough payments and discretionary spending being freed up when shops, restaurants, pubs, travel and so on were closed off. It did draw in retail investors though and several saw the pre|CISION potential whilst others didn't look beyond the LFT adventure.

Without that large spike I think we would have seen a classic S-shaped development curve, much more drawn out and with a lot more share dilution. Maybe even a collapse due to lack of management focus (looking at you Alan) and fundraising issues.

The ivermectin one came up in my recs feed only a week or two ago.

Fenbendazole — https://www.youtube.com/watch?v=ydV6HmQwAps

Ivermectin — https://www.youtube.com/watch?v=cuJecGa-sBA

UK Gov doing the dirty again. We'll never learn.

If we all heard this right, SGC data is to be presented at ASCO 2026: 'A phase Ia/Ib trial of FAP-Dox (AVA6000), a fibroblast activation protein (FAP)–released doxorubicin peptide drug conjugate in patients with FAP-positive solid tumors and activity against salivary gland cancers.'

https://www.asco.org/abstracts-presentations/264652

and there is no record of TNBC data being presented there, so what and where is the second conference?

Gemini says... Major international oncology conferences scheduled for May and June 2026 where triple-negative breast cancer (TNBC) data, such as for AVA6000, could be presented include:

Premier Global Oncology Conferences

• ASCO Annual Meeting 2026, 29 May – 2 June 2026 – apparently not this one

• ESMO Breast Cancer 2026, 6–8 May 2026 – passed

Specialized & Regional Congresses

• 13th Global Insight Conference on Breast Cancer (GICBC-2026), 29–30 June 2026 in Rome - last possible date

. . o Themes include novel discoveries in research and treatment

• 16th World Congress on Breast Cancer, 22–23 June 2026 in Dubai - Great congress ...but doubtful venue!💥🔥

• ASCO Breakthrough 2026, 25–27 June 2026, Singapore & Online

. . o Focuses on global innovation and technology in cancer care

Additional Specialized Meetings

• 4th Intl Conf on Cancer Biology & Therapeutics, 11–12 May 2026 in Rome – too soon

• 10th Global Meeting on Oncology and Radiology, 15–16 June 2026 in Paris

• 27th World Congress on Cancer Summit, 23–24 June 2026 in Paris

I can confirm I had the buffet lunch with D-Geeman, and HectorDog.

The presentations were what's already been presented at and post AACR plus a little bit more.

I found the presentations were mostly very difficult to follow as some speakers were low volume and almost mumbling and the recorded presentations from the US has a booming bass. But that may mainly have been due to my many years of loud rock and Congolese rumba. Rory (sp), with microphone, and Omer, the American regulatory guy, were loud and very clear though.

Any commercial news will come in the 7:00 RNS. As CC said on TwaX last Wednesday:

"As noted, we will be communicating any updates at the event via announcements on that morning and the video recording of the presentations will be made available as soon as editing is complete following the event. We look forward to next week."

https://x.com/coughlin582/status/2049527211741331881

I'm not expecting any commercial updates at 7am. No deals for AVA6000 indications, partner for AVA6103, or company to take AVA6207 forward. And I'm expecting absolutely no news concerning AstraZeneca, Bayer, E Merck, Novartis and/or Merck and what's more the possibility of any news of a company licensing pre|CISION to take forward their inhouse candidates, as will be explained on Science Day, is an complete non-starter.

Yeah, that revelation was a binner

Are you here all week? 🥺

It's a well known fact that sells drive the price up. Someone will be along shortly to explain.

That's OK IFA90, you can get me one in before you leave.

Queens Head, Denman Street, just off Piccadilly Circus

I'm going tomorrow, trains willing.

If anyone wants to say hello, I'll be the one with a black Jack Wolfskin rucksack with red straps.

It's all part of the graft

Pre|CISION meds are given as an intravenous infusion and are inert until cleaved by FAP. Blood takes about 20 seconds to circulate around the body so I don't see as it makes much difference whether the infusion is given over a minute (an injection) or an hour (a drip) and can't see why it would be given over a longer rather than a shorter duration, which isn't to say a longer duration wouldn't be preferred — perhaps a question for the Avacta team.

I can see with my own eyes as can anyone else but clearly not you AgentB

😳😂😂😂

What planet have you been on Bella? Trump is in Putin's pocket.

There are specialist databases for clinicians, as well as the clinicians having their own personal networks and professional contracts.